Official ESCRS | European Society of Cataract & Refractive Surgeons
Copenhagen 2016 Registration Programme Exhibitor Information Virtual Exhibition Satellite Meetings Glaucoma Day 2016 Hotel Star Alliance
title

10 - 14 Sept. 2016, Bella Center, Copenhagen, Denmark

This Meeting has been awarded 27 CME credits

 

escrs app advert yo advert

Posters

Search Title by author or title

Visual and refractive outcomes of the bioanalogic, polyfocal lens WIOL-CF after 3 months follow-up

Poster Details

First Author: E. Mertens BELGIUM

Co Author(s):                        

Abstract Details

Purpose:

The purpose of this study was to assess the visual and refractive outcomes of the bioanalogic, polyfocal lens WIOL-CF after 3 months follow-up.

Setting:

Medipolis, Antwerp Private Clinic, Belgium

Methods:

14 eyes of 7 patients underwent implantation of bioanalogic, polyfocal WIOL-CF lens (MEDICEM Technology s.r.o., Czech Republic). All surgeries were performed by one surgeon using FLACS. The lens power calculation was based on the Haigis formula. Main outcomes were evaluated during a 3 month follow-up period and included: binocular and monocular uncorrected visual acuity (UCVA), refraction, best corrected visual acuity (BCVA), distance corrected visual acuity (DCVA) and questionnaire with optical phenomena and spectacle independence evaluations.

Results:

The mean monocular logMAR results after three months : UCDVA 0.07±0.09; UCIVA 0.01±0.05; UCNVA 0.06±0.05; BCDVA 0.02±0.04; BCNVA 0.04±0.05; DCNVA 0.06±0.05. The mean sphere -0.25±0.43 D (ranging from -1.50 to 0.00D). The mean binocular logMAR results: UCDVA 0.05±0.05; UCIVA 0.00±0.06; UCNVA 0.06±0.05. No adverse events were found during the follow-up period. All patients were spectacle free. No complaints of excessive halos or glare were reported (only one patient reported mild phenomena).

Conclusions:

Bioanalogic, polyfocal IOL implantation after FLACS was a safe and effective method for pseudophakic presbyopia correction in patients at all distances.

Financial Disclosure:

One or more of the authors receives consulting fees, retainer, or contract payments from a company producing, developing or supplying the product or procedure presented

Back to Poster listing